Metronidazole USP from Japan
Metronidazole is an aromatic nitroimidazole derivative classified under HTS 2933.29.20.00 as a drug containing an unfused imidazole ring. It is primarily used as an antibiotic for treating anaerobic bacterial and protozoal infections.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.629%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide FDA Drug Master File and Certificate of Analysis confirming USP purity standards
• Ensure proper DEA scheduling documentation if applicable for bulk pharmaceutical imports
• Verify imidazole content via HPLC analysis to confirm classification under 2933.29.20.00